|
|
Allies in the Race Against Time: Navigating Alzheimer's Disease with Early Detection, Therapeutic Innovations, and Patient-Centric Care " Module Three
Target Audience
This activity is designed to meet the educational needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants
Program Overview
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in diseas... |
|
|
Allies in the Race Against Time: Navigating Alzheimer's Disease with Early Detection, Therapeutic Innovations, and Patient-Centric Care " Module Four
Target Audience
This activity is designed to meet the educational needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants.
Program Overview
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in disea... |
|
|
Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence for Improved Patient Outcomes
STATEMENT OF NEED
Head and neck cancers represent a heterogeneous group of tumors that originate in the lip/oral cavity, hypopharynx, oropharynx, nasopharynx, and larynx. An estimated 66,470 new cases are diagnosed in the United States annually, and 15,050 people die of the disease (Siegel et al, 2022). Approximately 90% of cases are classified as head and neck squamous cell carcinoma (HNSCC). Treatment of HNSCC is complicated by numerous factors, including differing therapeutic strategies ... |
|
|
Case Studies in Multiple Sclerosis and Aging
• Identify the clinical difference between age-related/neurodegenerative cognitive decline and MS-related cognitive impairment.
• Discuss the role of potential biomarkers in identifying coexisting neurodegenerative disorders.
• Explain why it is important for the care team to address comorbid vascular risk factors for cognitive decline, including lifestyle modification and healthy behaviors
https://academycme.org/pdfs/MSAging.pdf |
|